BIOSYNTIA ApS: Financial statements 2017
CVR: 34892970
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 2,197,797 and a net result of DKK -3,210,394 compared with DKK -2,837,632 the year before. That is an increase of 254.9% compared with the year before. Equity in the 2017 report amounted to DKK 4,817,878. The solvency ratio was 74.1%. The company had 14 employees in the financial year.
- Gross Profit
- DKK 2,197,797
- Profit/Loss
- DKK -3,210,394
- Equity
- DKK 4,817,878
- Total Assets
- DKK 6,503,468
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 2.2 mio. | -3.2 mio. | 4.8 mio. | 14 |
| 2016 | - | 619 t. | -2.8 mio. | 8 mio. | 8 |
| 2015 | - | 1.2 mio. | -1.7 mio. | 3.9 mio. | - |
| 2014 | - | 1.6 mio. | -4 t. | 48 t. | - |
| 2013 | - | 389 t. | -28 t. | 52 t. | - |
Official annual report
Keep an eye on BIOSYNTIA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of July 15, 2017, Martin Plambech is registered as adm. dir. of BIOSYNTIA ApS.
As of July 15, 2017, Morten Otto Alexander Sommer has stepped down as adm. dir. of BIOSYNTIA ApS.
BIOSYNTIA ApS has published its annual report for 2016. Gross profit came to DKK 619,242, and the net result was DKK -2,837,632.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The board consists of Henrik Dalbøge (chair), Joško Bobanović and Thomas Grotkjær. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees (2018). In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity in the 2025 report amounted to DKK 32,860,576.